REG - Transense Technlgy - Completion of Capital Reduction

Transense TechnologiesAnnouncement

28/01/2021 07:01

RNS Number : 1246N
  
Transense Technologies PLC
  
28 January 2021
  
 

28 January 2021
 
Transense Technologies plc 
("Transense", or "the Company")
 
Completion of Capital Reduction
 
Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, announces that the Capital Reduction, details of which were set out in the Company's circular and Notice of AGM dated 23 November 2020, and approved by shareholders at the AGM on 17 December 2020, has been confirmed by the High Court at a hearing dated 26 January 2021 and will become effective upon registration of the court order and statement of capital at Companies House, which is expected to occur during the course of February 2021.
 
 
For further information please visit www.transense.com or contact:
 



Transense Technologies plc
Nigel Rogers (Executive Chairman)
Melvyn Segal (CFO) 


Via Walbrook PR




Allenby Capital (Nominated Adviser and Broker)
Jeremy Porter/James Reeve/Asha Chotai (Corporate Finance)
Tony Quirke (Sales and Corporate Broking)


Tel: +44 (0)20 3328 5656




Walbrook PR
Tom Cooper/Nick Rome/Nicholas Johnson


Tel: +44 (0)20 7933 8780
Transense@walbrookpr.com



Notes to Editors:
 
Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring.  Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, recently licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.
 
The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.
 
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.  www.transense.com
For further information please contact transense@walbrookpr.com.
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
MSCEAPFXAFLFEFA